Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA
Research output: Contribution to journal › Journal article › Research › peer-review
Murat Fani Bozkurt, Irene Virgolini, Sona Balogova, Mohsen Beheshti, Domenico Rubello, Clemens Decristoforo, Valentina Ambrosini, Andreas Kjaer, Roberto Delgado-Bolton, Jolanta Kunikowska, Wim J G Oyen, Arturo Chiti, Francesco Giammarile, Stefano Fanti
PURPOSE & METHODS: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using68Ga-DOTA-conjugated peptides, as well as18F-DOPA imaging for various neuroendocrine neoplasms.
RESULTS & CONCLUSION: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
|Journal||European Journal of Nuclear Medicine and Molecular Imaging|
|Number of pages||14|
|Publication status||Published - Aug 2017|
- Dihydroxyphenylalanine/analogs & derivatives, Gallium Radioisotopes, Heterocyclic Compounds, 1-Ring/chemistry, Humans, Image Interpretation, Computer-Assisted, Neuroendocrine Tumors/diagnostic imaging, Peptides/chemistry, Positron Emission Tomography Computed Tomography/methods, Practice Guidelines as Topic, Quality Control, Receptors, Somatostatin/metabolism, Tissue Distribution